Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Inventory (2020 - 2025)

Historic Change in Inventory for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $463867.0.

  • KORU Medical Systems' Change in Inventory fell 6537.19% to $463867.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $483392.0, marking a year-over-year increase of 16457.32%. This contributed to the annual value of -$677632.0 for FY2024, which is 7682.17% up from last year.
  • Latest data reveals that KORU Medical Systems reported Change in Inventory of $463867.0 as of Q3 2025, which was down 6537.19% from $669197.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Change in Inventory registered a high of $1.3 million during Q3 2024, and its lowest value of -$1.4 million during Q2 2023.
  • Over the past 5 years, KORU Medical Systems' median Change in Inventory value was -$333989.0 (recorded in 2024), while the average stood at -$127266.4.
  • Over the last 5 years, KORU Medical Systems' Change in Inventory had its largest YoY gain of 36359.86% in 2023, and its largest YoY loss of 63382.49% in 2023.
  • KORU Medical Systems' Change in Inventory (Quarter) stood at -$861594.0 in 2021, then soared by 44.37% to -$479289.0 in 2022, then plummeted by 149.46% to -$1.2 million in 2023, then increased by 5.94% to -$1.1 million in 2024, then soared by 141.25% to $463867.0 in 2025.
  • Its Change in Inventory stands at $463867.0 for Q3 2025, versus $669197.0 for Q2 2025 and $474977.0 for Q1 2025.